Meeting Banner
Abstract #1860

in vivo Tracking of Ferumoxytol Labeled NK Cells Using MRI

Naomi Santa Maria1, Thomas Ng, Sharon Lin, Sarah McCaig2, Desiree Crow2, Jianyi Wang2, Andrew Raubitschek2, Russell E. Jacobs

1Biology, Caltech, Pasadena, CA, United States; 2City of Hope, Duarte, CA, United States

MRI can provide a noninvasive tool to characterize adoptive NK cell therapy. We aimed to implement MRI-based NK cell tracking methods that could be clinically translatable by using an FDA-approved USPIO cell label on NK cells isolated from human peripheral blood. MRI as a noninvasive in vivo cellular imaging technique could further elucidate optimization of adoptive NK cell transfer as a cancer therapy.

Keywords

accordance according administration adoptive agent aimed animal animals anti antigens approved audience biology blood cancer cancers care cell cells cellular characterize city clinically clinicians components computed consisted continues correlated corresponded critical crow cytotoxic decrease defined determined distribution dose eight elucidate elucidation evaluation experimental gamma genotype gradient groin hope human immune implanted implement implementation in vivo incubation injected injection investigated iron isolated killer killers label labeled labeling leukemia live liver lymphoma mapping maria matrix mechanisms mediated mice model mouse much muscle natural noninvasive nude null optimization orbitally oxide percent peripheral policies post presence prior procedures promise promote reactivity resolution saline scanner scanning scientist significantly site slice spacing specificity spleen still student subcutaneously subjects sulfate system target targeting therapy tissues tool tracking trafficking transfer translatable treated tumor tumors underlying unknown uptake week whether